Skip to main content
Doris Quon, MD, Hematology, Los Angeles, CA

Doris Quon MD


Physician

Join to View Full Profile
  • 403 W. Adams Blvd.Los Angeles, CA 90007

  • Phone+1 213-742-1000

  • Fax+1 213-742-1000

Dr. Quon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2003
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1996 - 1999
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - 2025
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A  
    Doris V Quon, Margaret V Ragni, The New England Journal of Medicine
  • Development and Reliability of the Joint Tissue Activity and Damage Examination for Quantitation of Structural Abnormalities by Musculoskeletal Ultrasound in Hemophili...  
    Eric Y Chang, Annette von Drygalski, Doris V Quon, Tudor H Hughes, Journal of Ultrasound in Medicine

Abstracts/Posters

  • Quantitative Measurements of Hemophilic Joint Tissues By Point-of-Care Musculoskeletal Ultrasound Are Associated with Clinical and Functional Joint Outcome Parameters
    Doris Quon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • BioMarin Announces New England Journal of Medicine Publishes 3 Years of Follow-up Data in Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
    BioMarin Announces New England Journal of Medicine Publishes 3 Years of Follow-up Data in Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Hemophilia AJanuary 2nd, 2020
  • Clinical Challenge: From Pediatric to Adult Hemophilia Care
    Clinical Challenge: From Pediatric to Adult Hemophilia CareDecember 17th, 2019
  • California's Most Expensive Patient in Recent Years Has Hemophilia
    California's Most Expensive Patient in Recent Years Has HemophiliaMarch 6th, 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: